Cited 52 time in
Orally disintegrating films focusing on formulation, manufacturing process, and characterization
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lee, Y. | - |
| dc.contributor.author | Kim, K. | - |
| dc.contributor.author | Kim, M. | - |
| dc.contributor.author | Choi, D.H. | - |
| dc.contributor.author | Jeong, S.H. | - |
| dc.date.accessioned | 2024-09-26T13:31:07Z | - |
| dc.date.available | 2024-09-26T13:31:07Z | - |
| dc.date.issued | 2017-05-01 | - |
| dc.identifier.issn | 2093-5552 | - |
| dc.identifier.issn | 2093-6214 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/25222 | - |
| dc.description.abstract | Orally disintegrating films (ODF) has recently become one of the most popular forms of drug administration due to its excellent patient convenience and compliance. The main advantage of the dosage form arises from rapid disintegration: it can be placed on the tongue without the need of water. Compared to conventional oral dosage forms, ODFs usually result in enhanced bioavailability with faster onset of action. In addition, ODFs are flexible. Unlikely to orally disintegrating tablets, they do not require any special packaging for protection during transportation and storage. The critical quality attributes (CQAs) of ODFs should be carefully considered during the development process. These properties are not only inherent to the formulation but are also significantly influenced by the manufacturing processes. This review provides a brief overview of the advantages, formulation considerations, critical manufacturing processes and methods, characterization, and CQAs of ODFs, which might be beneficial to understand the dosage form better in a comprehensive way. © 2017, The Korean Society of Pharmaceutical Sciences and Technology. | - |
| dc.format.extent | 19 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Springer Netherlands | - |
| dc.title | Orally disintegrating films focusing on formulation, manufacturing process, and characterization | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.1007/s40005-017-0311-2 | - |
| dc.identifier.scopusid | 2-s2.0-85018725523 | - |
| dc.identifier.bibliographicCitation | Journal of Pharmaceutical Investigation, v.47, no.3, pp 183 - 201 | - |
| dc.citation.title | Journal of Pharmaceutical Investigation | - |
| dc.citation.volume | 47 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 183 | - |
| dc.citation.endPage | 201 | - |
| dc.type.docType | Review | - |
| dc.identifier.kciid | ART002224417 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.subject.keywordAuthor | Film characterization | - |
| dc.subject.keywordAuthor | Formulation | - |
| dc.subject.keywordAuthor | Manufacturing process | - |
| dc.subject.keywordAuthor | Orally disintegrating film | - |
| dc.subject.keywordAuthor | Quality attributes | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
